Clinical trial
Kidney Disease in Type 2 Diabetes Mellitus: Biomarker Discovery and Novel Therapeutics
NCT02410005 is registered in ClinicalTrials.gov with Weill Cornell Medical College in Qatar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Kidney Disease in Type 2 Diabetes Mellitus: Biomarker Discovery and Novel Therapeutics
- Lead sponsor
- Weill Cornell Medical College in Qatar
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- October 31, 2014
- Completion date
- September 7, 2015
- Enrollment
- 56 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.